These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 31902237)
1. SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)-Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome Activation. Tang X; Pan L; Zhao S; Dai F; Chao M; Jiang H; Li X; Lin Z; Huang Z; Meng G; Wang C; Chen C; Liu J; Wang X; Ferro A; Wang H; Chen H; Gao Y; Lu Q; Xie L; Han Y; Ji Y Circulation; 2020 Mar; 141(12):984-1000. PubMed ID: 31902237 [TBL] [Abstract][Full Text] [Related]
2. S-nitrosylation of Hsp90 promotes cardiac hypertrophy in mice through GSK3β signaling. Zhao S; Song TY; Wang ZY; Gao J; Cao JW; Hu LL; Huang ZR; Xie LP; Ji Y Acta Pharmacol Sin; 2022 Aug; 43(8):1979-1988. PubMed ID: 34934196 [TBL] [Abstract][Full Text] [Related]
3. Cardiac remodeling is not modulated by overexpression of muscle LIM protein (MLP). Kuhn C; Frank D; Dierck F; Oehl U; Krebs J; Will R; Lehmann LH; Backs J; Katus HA; Frey N Basic Res Cardiol; 2012 May; 107(3):262. PubMed ID: 22421737 [TBL] [Abstract][Full Text] [Related]
4. NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload. Higashikuni Y; Liu W; Numata G; Tanaka K; Fukuda D; Tanaka Y; Hirata Y; Imamura T; Takimoto E; Komuro I; Sata M Circulation; 2023 Jan; 147(4):338-355. PubMed ID: 36440584 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways. Singh MV; Cicha MZ; Nunez S; Meyerholz DK; Chapleau MW; Abboud FM Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1027-H1038. PubMed ID: 30793936 [TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1/NF-κB pathway. Ren B; Feng J; Yang N; Guo Y; Chen C; Qin Q Int Immunopharmacol; 2021 Sep; 98():107841. PubMed ID: 34153662 [TBL] [Abstract][Full Text] [Related]
7. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling. Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855 [TBL] [Abstract][Full Text] [Related]
8. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca Suetomi T; Willeford A; Brand CS; Cho Y; Ross RS; Miyamoto S; Brown JH Circulation; 2018 Nov; 138(22):2530-2544. PubMed ID: 30571348 [TBL] [Abstract][Full Text] [Related]
9. RIP3 Contributes to Cardiac Hypertrophy by Influencing MLKL-Mediated Calcium Influx. Xue H; Shi H; Zhang F; Li H; Li C; Han Q Oxid Med Cell Longev; 2022; 2022():5490553. PubMed ID: 35464769 [TBL] [Abstract][Full Text] [Related]
10. Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury. Su Q; Li L; Sun Y; Yang H; Ye Z; Zhao J Cell Physiol Biochem; 2018; 47(4):1497-1508. PubMed ID: 29940584 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of HSP90 S-nitrosylation alleviates cardiac fibrosis via TGFβ/SMAD3 signalling pathway. Zhang X; Zhang Y; Miao Q; Shi Z; Hu L; Liu S; Gao J; Zhao S; Chen H; Huang Z; Han Y; Ji Y; Xie L Br J Pharmacol; 2021 Dec; 178(23):4608-4625. PubMed ID: 34265086 [TBL] [Abstract][Full Text] [Related]
13. S-nitrosylation of c-Jun N-terminal kinase mediates pressure overload-induced cardiac dysfunction and fibrosis. Zhou M; Chen JY; Chao ML; Zhang C; Shi ZG; Zhou XC; Xie LP; Sun SX; Huang ZR; Luo SS; Ji Y Acta Pharmacol Sin; 2022 Mar; 43(3):602-612. PubMed ID: 34011968 [TBL] [Abstract][Full Text] [Related]
14. Semaglutide ameliorates pressure overload-induced cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome. He W; Wei J; Liu X; Zhang Z; Huang R; Jiang Z Sci Rep; 2024 May; 14(1):11824. PubMed ID: 38782946 [TBL] [Abstract][Full Text] [Related]
15. Trimethylamine-N-Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3-SOD2-mtROS Signaling Pathway. Chen ML; Zhu XH; Ran L; Lang HD; Yi L; Mi MT J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28871042 [TBL] [Abstract][Full Text] [Related]
16. S-Nitrosylation of Septin2 Exacerbates Aortic Aneurysm and Dissection by Coupling the TIAM1-RAC1 Axis in Macrophages. Zhang Y; Zhang H; Zhao S; Qi Z; He Y; Zhang X; Wu W; Yan K; Hu L; Sun S; Tang X; Zhou Q; Chen F; Gu A; Wang L; Zhang Z; Yu B; Wang D; Han Y; Xie L; Ji Y Circulation; 2024 Jun; 149(24):1903-1920. PubMed ID: 38357802 [TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation. Guo C; Fu R; Zhou M; Wang S; Huang Y; Hu H; Zhao J; Gaskin F; Yang N; Fu SM J Autoimmun; 2019 Sep; 103():102286. PubMed ID: 31133359 [TBL] [Abstract][Full Text] [Related]
19. RIP3 dependent NLRP3 inflammasome activation is implicated in acute lung injury in mice. Chen J; Wang S; Fu R; Zhou M; Zhang T; Pan W; Yang N; Huang Y J Transl Med; 2018 Aug; 16(1):233. PubMed ID: 30126430 [TBL] [Abstract][Full Text] [Related]
20. CTRP3 inhibits myocardial fibrosis through the P2X7R-NLRP3 inflammasome pathway in SHR rats. Liu N; Gong Z; Li Y; Xu Y; Guo Y; Chen W; Sun X; Yin X; Liu W J Hypertens; 2024 Feb; 42(2):315-328. PubMed ID: 37850974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]